Literature DB >> 11292756

Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes.

J S Shin1, J S Lin, P W Anderson, R A Insel, M H Nahm.   

Abstract

From five mice immunized with Escherichia coli K1 bacteria, we produced 12 immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) that bind to Neisseria meningitidis group B (NMGB). The 12 MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is alpha(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing alpha(2-8) PSA. Except for HmenB5, which cross-reacted with N. meningitidis group C, none of the MAbs bound to N. meningitidis groups A, C, and Y. Of the 12 MAbs, 6 were autoantibodies as defined by binding to CHP-134, a neuroblastoma cell line expressing short-chain alpha(2-8) PSA; five of these MAbs killed NMGB in the presence of rabbit complement, and two also killed NMGB with human complement. The other six MAbs, however, were nonautoreactive; all killed NMGB with rabbit complement, and five killed NMGB with human complement. To obtain peptide mimotopes of NMGB PS, four of the nonautoreactive MAbs (HmenB2, HmenB3, HmenB13, and HmenB14) were used to screen two types of phage libraries, one with a linear peptide of 7 amino acids and the other with a circular peptide of 7 amino acids inserted between two linked cysteines. We obtained 86 phage clones that bound to the screening MAb in the absence but not in the presence of E. coli K1 PSA in solution. The clones contained 31 linear and 4 circular mimotopes expressing unique sequences. These mimotopes nonrandomly expressed amino acids and were different from previously described mimotopes for NMGB PS. The new mimotopes may be useful in producing a vaccine(s) capable of eliciting anti-NMGB antibodies not reactive with neuronal tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292756      PMCID: PMC98292          DOI: 10.1128/IAI.69.5.3335-3342.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  The contribution of ER quality control to the biologic functions of secretory IgM.

Authors:  P S Reddy; R B Corley
Journal:  Immunol Today       Date:  1999-12

2.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

3.  Biological correlates of capsular (quellung) reactions of Cryptococcus neoformans.

Authors:  T C MacGill; R S MacGill; A Casadevall; T R Kozel
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

4.  Monoclonal antibodies to streptococcal group A carbohydrate. I. A dominant idiotypic determinant is located on Vk.

Authors:  M H Nahm; B L Clevinger; J M Davie
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

5.  Immunoprophylaxis of meningococcal infection.

Authors:  M S Artenstein; P E Winter; R Gold; C D Smith
Journal:  Mil Med       Date:  1974-02       Impact factor: 1.437

6.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Authors:  M Pizza; V Scarlato; V Masignani; M M Giuliani; B Aricò; M Comanducci; G T Jennings; L Baldi; E Bartolini; B Capecchi; C L Galeotti; E Luzzi; R Manetti; E Marchetti; M Mora; S Nuti; G Ratti; L Santini; S Savino; M Scarselli; E Storni; P Zuo; M Broeker; E Hundt; B Knapp; E Blair; T Mason; H Tettelin; D W Hood; A C Jeffries; N J Saunders; D M Granoff; J C Venter; E R Moxon; G Grandi; R Rappuoli
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

7.  Alterations in neural cell adhesion molecules during development of different regions of the nervous system.

Authors:  C M Chuong; G M Edelman
Journal:  J Neurosci       Date:  1984-09       Impact factor: 6.167

8.  Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

Authors:  H J Jennings; C Lugowski
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

9.  Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM.

Authors:  C T Hughey; J W Brewer; A D Colosia; W F Rosse; R B Corley
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

10.  Lipid on capsular polysaccharides of gram-negative bacteria.

Authors:  E C Gotschlich; B A Fraser; O Nishimura; J B Robbins; T Y Liu
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

View more
  9 in total

1.  Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies.

Authors:  Gregory R Moe; Apurva Dave; Dan M Granoff
Journal:  Mol Immunol       Date:  2005-09-02       Impact factor: 4.407

2.  Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.

Authors:  In Ho Park; Ju Ho Youn; In-Hong Choi; Moon H Nahm; Se Jong Kim; Jeon-Soo Shin
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody.

Authors:  Gregory R Moe; Apurva Dave; Dan M Granoff
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.

Authors:  John B Robbins; Rachel Schneerson; Guilin Xie; Lars Å Hanson; Lars Åke-Hanson; Mark A Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

5.  Prospective identification of parasitic sequences in phage display screens.

Authors:  Wadim L Matochko; S Cory Li; Sindy K Y Tang; Ratmir Derda
Journal:  Nucleic Acids Res       Date:  2013-11-11       Impact factor: 16.971

6.  Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci.

Authors:  Concetta Beninati; Angelina Midiri; Giuseppe Mancuso; Carmelo Biondo; Milena Arigò; Elisabetta Gerace; Salvatore Papasergi; Maria Gambuzza; Mauro Boretti; Walter Magliani; Stefania Conti; Luciano Polonelli; Giuseppe Teti
Journal:  J Exp Med       Date:  2006-01-03       Impact factor: 14.307

Review 7.  Vaccine development against Neisseria meningitidis.

Authors:  Ulrich Vogel; Heike Claus
Journal:  Microb Biotechnol       Date:  2011-01       Impact factor: 5.813

8.  Rational Design and Evaluation of an Artificial Escherichia coli K1 Protein Vaccine Candidate Based on the Structure of OmpA.

Authors:  Hao Gu; Yaling Liao; Jin Zhang; Ying Wang; Zhiyong Liu; Ping Cheng; Xingyong Wang; Quanming Zou; Jiang Gu
Journal:  Front Cell Infect Microbiol       Date:  2018-05-23       Impact factor: 5.293

Review 9.  Phage display: selecting straws instead of a needle from a haystack.

Authors:  Miha Vodnik; Urska Zager; Borut Strukelj; Mojca Lunder
Journal:  Molecules       Date:  2011-01-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.